Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Vietnam's healthcare M&A market surged in 2025, led by private equity investments in established providers, making it Southeast Asia’s most active market.
Vietnam’s healthcare M&A market surged in 2025, driven by private equity and institutional investors targeting established, multi-location providers in specialties like oncology and cardiology.
Key deals, including Ares’s investment in Medlatec and Quadria Capital’s acquisition of Tam Tri Medical, reflected growing global interest in Vietnam’s certified, export-ready healthcare platforms.
Activity concentrated in Hanoi and Ho Chi Minh City, with secondary cities gaining traction.
PE-backed firms expanded through bolt-on acquisitions, while investments from 2020–2022 approached exit windows, potentially setting new valuation benchmarks.
The sector’s momentum, supported by strong margins and regional trade advantages, solidified Vietnam’s status as Southeast Asia’s most active healthcare M&A market.
El mercado de fusiones y adquisiciones de atención médica de Vietnam se disparó en 2025, liderado por inversiones de capital privado en proveedores establecidos, lo que lo convierte en el mercado más activo del sudeste asiático.